Intimation of Closure of Trading Window for the quarter ending on June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has informed the stock exchanges that its trading window for dealing in securities will remain closed for insiders, including directors, key managerial personnel, and designated employees, in connection with the quarter ending June 30, 2025. This is a mandatory compliance measure under SEBI's Insider Trading Regulations (PIT Regulations, 2015). The closure typically begins before the end of the quarter and remains in effect until 48 hours after the announcement of unaudited financial results. It is a routine regulatory filing and not a corporate action with financial impact.
No direct impact on shareholders or stock price. This is a standard compliance disclosure indicating that Q1FY26 results are expected to be announced soon, which is the only material event for investors to watch.